Report cover image

Global Leadless Pacemaker market - 2024-2031

Publisher DataM Intelligence 4Market Research LLP
Published Mar 08, 2024
Length 186 Pages
SKU # DTAM18609029

Description

Global Leadless Pacemaker market - 2024-2031


Global Leadless Pacemaker market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

A leadless pacemaker is a medical device that is implanted right inside the heart without the implantation of leads in the heart or a separate battery under the heart. It comes with a lot of advantages when compared to conventional pacemakers such as reduced infection risk at the site, lead dislodgment, and blood clots.

Market Dynamics: Drivers & Restraints

Increasing Market Developments

Pacemaker systems have undergone rapid advancements such as increased battery life, reduced generator size, and other improvements that increased the efficiency of leadless pacemakers. Advancements in battery technologies, and the development of sophisticated devices.

In July 2021, MicroPort, Cardiac Rhythm Management Limited (a subsidiary of Cardiac invested US$150 Million in the development of implantable devices and defibrillators. In addition, MicroPort CRM is currently developing a sub-cutaneous ICD (S-ICD) and a leadless pacemaker. In April 2022, Cairdac raised $18.5M in funding for developing a leadless pacemaker transcatheter system (ALPS) powered entirely using kinetic energy from the heart.

High incidence of battery malfunction

Failure of the device can be seen due to the battery malfunction. For instance, according to AHA journals organization, 2023, there was a high incidence of battery failure of the Nanostim LCP in a long time. More than 40% of devices failed after 3 years. Pacemaker battery depletion occurs due to inadequate follow-up procedures. Leadless pacemakers fail to integrate with defibrillator systems.

Segment Analysisn

The global leadless pacemaker market is segmented based on type, product, application end-user and region.

Dual-chamber type is Expected to Dominate the Market

A dual-chamber leadless pacemaker is used for a wider range of treatment options as it consists of 2 devices. An increase in approvals by the FDA is expected to drive the market in the forecast period. For instance, in May 2023, Medtronic plc received U.S. Food and Drug Administration (FDA) approval for its Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemakers.

In July 2023, Abbott received the U.S. Food and Drug Administration (FDA) approval for the AVEIR dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms.

In January 2022, Medtronic plc received regulatory approval from Japan's Ministry of Health, Labor, and Welfare for the sale and reimbursement of the Micra AV Transcatheter Pacing System (TPS).

Geographical Analysis

North America is Expected to Dominate the Global Market

North America is expected to hold the largest share of the market due to the increase in cardiovascular diseases in the US and Canada. For instance, according to the American Heart Association, 2024, heart disease has been a leading cause of death for the past 100 years. Approximately, 46.7% of U.S. adults have high blood pressure. Yet, over 38% of those with high blood pressure are unaware that they have it.

Furthermore, according to the Journal of Cardiac Failure, approximately 6.7 million Americans over 20 years of age have poor heart, and the prevalence of cardiac failure is expected to rise to 8.5 million Americans by 2030.

Market Segmentation

By Type
• Single Chamber
• Dual Chamber

By Product
• Micra Transcatheter Pacing System
• Nanostim Leadless Pacemaker
• Others

By Application
• Atrial Fibrillation
• Sinus Node Dysfunction
• Bradycardia-tachycardia syndrome
• Others

By End User
• Hospital Pharmacies
• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Outpatient Facilities
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Key Developments
• In February 2022, Abbott released the world's first patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i pivotal clinical study.

Competitive Landscape

The major global players in the leadless pacemaker market include Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, MicroPort Scientific Corporation, EBR Systems, Inc, Biotronik, CAIRDAC, Lepu Medical Technology (Beijing)Co., Ltd., Nanostim Inc among others.

Why Purchase the Report?
• To visualize the global leadless pacemaker market segmentation based on type, product, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of leadless pacemaker market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global leadless pacemaker market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

186 Pages
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Product
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Market Developments
4.1.1.2. YY
4.1.2. Restraints
4.1.2.1. High incidence of battery malfunction
4.1.2.2. YY
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. Pipeline Analysis
5.8. Epidemiology
5.9. SWOT Analysis
5.10. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Single Chamber*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Dual Chamber
8. By Product
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
8.1.2. Market Attractiveness Index, By Product
8.2. Micra Transcatheter Pacing System*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Nanostim Leadless Pacemaker
8.4. Others
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Atrial Fibrillation*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Sinus Node Dysfunction
9.4. Bradycardia-tachycardia syndrome
9.5. Others
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Cardiac Centers
10.4. Ambulatory Surgical Centers
10.5. Outpatient Facilities
10.6. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Medtronic Plc*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Abbott Laboratories
13.3. Boston Scientific Corporation
13.4. MicroPort Scientific Corporation
13.5. EBR Systems, Inc
13.6. Biotronik
13.7. CAIRDAC
13.8. Lepu Medical Technology (Beijing)Co., Ltd.
13.9. Nanostim Inc
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us